Skip to content

Evaluation of improvement of higher brain function and safety by Collagen food containing tripeptide and cyclic dipeptide intake.

Evaluation of improvement of higher brain function and safety by Collagen food containing tripeptide and cyclic dipeptide intake. - Evaluation of improvement of higher brain function and safety test

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030194
Enrollment
16
Registered
2017-12-01
Start date
2017-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Low dose:1 bag once a day :During meals once a day, take in miso soup, coffee, tea etc. together with hot drinks that are usually drunk and ingest them together. Or take a meal with water or lukewarm

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Japanese male and female at the age of 40 to 69 at first observation including screening. 2 A person who feels more forgetful than early life.

Exclusion criteria

Exclusion criteria: 1 A person who possibly shows food allergy symptom. 2 A person who had been treated, hospitalized or operated for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral haemorrhage, brain contusion or head trauma. 3 A person who is alcohol or nicotine addict, or whose dietary habit is extremely irregular. 4 A person with medical history or current illness of hepatic disorder. 5 A person with severe anemia. 6 A person with medical history of epileptic stroke, diabetes, thyroid dysfunction or severe renal dysfunction(hemodialysis, uremia, anuria), or attending the hospital regularly for these disorder. 7 A person who has taken a neuropsychological test at hospital. 8 A person who joins other human clinical study. 9 A person who is routinely taking medicines (e.g. antipsychotic, antianxiety agent, antidepressant, antiparkinson agent, antimanic agent, anticonvulsant, anticoagulant agent) which possibly affects the test results. 10 A person who is routinely taking health foods (supplements effective for antioxidative, blood flow-ameliorating and so on) which possibly affects the test results. 11 A person who is judged inappropriate to join the study by doctor in charge. (Subject who is judged inappropriate during this test is excluded from targets of analysis. In addition, a criterion not in screening criteria is not included in exclusion criteria for screening.) 12 A person who have taken an RBANS test in 3 month before main test schedule.

Design outcomes

Primary

MeasureTime frame
2 month later , evaluation of cognitive functions by RBANS

Secondary

MeasureTime frame
Blood test Health diary Doctor's findings and evaluations Height measurement Physical measurement Measurement of blood pressure and pulse

Countries

Japan

Contacts

Public ContactKo MASUDA

SOUKEN Co., Ltd Management Division

k_masuda@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026